Search

Displaying results 4311 - 4320 of 10000 in total
  1. Drug

    CNS-5161

    go.drugbank.com/drugs/DB05824
    Experimental

    CNS 5161 is a blocker of the NMDA ion channel and has completed Phase IIa proof of concept clinical trials as a novel compound for the treatment of neuropathic pain.

  2. Drug

    Sodium feredetate

    go.drugbank.com/drugs/DB13381
    Approved

    Synonyms: Feredato de sodio, Ferédétate de sodiumCategories: Compounds used in a research, industrial, or household setting
  3. Drug

    Iobenzamic acid

    go.drugbank.com/drugs/DB13428
    Experimental

    Categories: Compounds used in a research, industrial, or household setting, Diagnostic Uses of Chemicals
  4. Drug

    Ioglycamic acid

    go.drugbank.com/drugs/DB13741
    Experimental

    Categories: Compounds used in a research, industrial, or household setting, Diagnostic Uses of Chemicals
  5. Drug

    Cintirorgon

    go.drugbank.com/drugs/DB20916
    Investigational

    Cintirorgon has a monoisotopic molecular weight of 603.12 Da. … Cintirorgon is a small molecule drug. Cintirorgon is under investigation in clinical trial NCT02929862 (Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic Cancer).

  6. Drug

    Domazoline

    go.drugbank.com/drugs/DB19937
    Experimental

    Domazoline has a monoisotopic molecular weight of 248.15 Da. … Domazoline is a small molecule drug. The usage of the INN stem '-azoline' in the name indicates that Domazoline is a antihistaminic or local vasoconstrictor, antazoline derivative.

  7. Drug

    Coumazoline

    go.drugbank.com/drugs/DB21226
    Experimental

    Coumazoline has a monoisotopic molecular weight of 228.13 Da. … Coumazoline is a small molecule drug. The usage of the INN stem '-azoline' in the name indicates that Coumazoline is a antihistaminic or local vasoconstrictor, antazoline derivative.

  8. Drug

    Lazuvapagon

    go.drugbank.com/drugs/DB19046
    Investigational

    Lazuvapagon is under investigation in clinical trial NCT03116191 (Trial of SK-1404 for Nocturia Due to Nocturnal Polyuria in Japanese Subjects).

  9. Drug

    Tetrahydropalmatine

    go.drugbank.com/drugs/DB12093
    Investigational

    Tetrahydropalmatine is under investigation in clinical trial NCT02118610 (Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal

    Categories: Dopamine D2 Receptor Antagonists, Heterocyclic Compounds with 4 or More Rings
  10. Drug

    Elesclomol

    go.drugbank.com/drugs/DB05719
    Investigational

    In preclinical models elesclomol showed potent killing of a broad range of cancer cell types at high doses, and an ability to strongly enhance the efficacy of certain chemotherapy agents, with minimal … additional toxicity, at moderate doses.